Skip to content

Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • A new treatment for pancreatic cancer has been developed that on average increases survival from from six months to 12 but Canadians don’t have access to it. Here’s why.

    July 15, 2026

    Medical Mythbusting Commentary for July 15, 2026 Source:A new cancer treatment is hailed as a breakthrough, but Canadians don’t have access to it. Here’s why.

  • Genetic/molecular mechanism discovered to explain why heart muscle does not develop cancer or at least rarely does so.

    June 29, 2026

    Medical Mythbusting Commentary for June 29, 2026 Source:Why Does the Heart Rarely Develop Cancer?

  • Conflicting studies evaluating cancer risk after removal of the thymus.

    June 18, 2026

    Medical Mythbusting Commentary for June 18, 2026 Source:A ‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer Reference:The Thymus: Function and the Debate Over Its Removal The thymus is a small organ located behind the breastbone, in front of the heart. It serves as the “training ground” for T cells — the immune system’s soldiers that…

  • New medication for the treatment of advanced pancreatic cancer increases median overall survival from 6.7 to 13.2 months.

    June 1, 2026

    Medical Mythbusting Commentary for June 1, 2026 Source:‘I actually started crying’: Oncologist reacts to pancreatic cancer drug results Synopsis of the article and study: Benefits: Doubled survival, oral convenience, targeted action, manageable side effects. Limitations: Grade 3+ adverse events in about one-third of patients; still experimental, not yet fully approved; tested in advanced cases post-chemo.

  • Observational study noted that patients with diabetes and obesity using GLP-1 medications may experience reduced degree of metastases. Causality confirmation and mechanisms to be determined.

    May 25, 2026

    Medical Mythbusting Commentary for May 25, 2026 Source:GLP-1 Users May Experience A Surprising Life-Saving Benefit That Has Nothing To Do With Weight Loss

  • Ex Vivo Study Examines an Invented Chewing Gum That Might Help Fight Oral Cancers Caused by HPV….. Some Day, Maybe.

    May 1, 2026

    Medical Mythbusting Commentary for May 1, 2026 Source:Scientists Invented a Chewing Gum That Might Help Fight Cancer Some Day Reference:Ex vivo HNSCC clinical studies using saliva and antiviral or antibacterial chewing gums reveal reduction in carcinogenic microbes

  • Bone marrow transplantation from a select group of donors with HIV resistant cells is provided to a Toronto man with HIV to treat his leukemia now shows sustained remission of his HIV infection.

    April 27, 2026

    Medical Mythbusting Commentary for April 27, 2026 Source:In a Canadian first, a Toronto man’s HIV is in sustained remission. Here’s how scientists achieved it

  • In Vitro Lab Study on Sucralose Impurity Shows DNA Damage at Unrealistically High Doses; No Evidence of Human Toxicity at Normal Splenda Use

    April 20, 2026

    Medical Mythbusting Commentary for April 20, 2026 Source:Popular Sweetener Linked to DNA Damage – “It’s Something You Should Not Be Eating” Reference:Toxicological and pharmacokinetic properties of sucralose-6-acetate and its parent sucralose: in vitro screening assays The SciTechDaily article from April 16, 2026 summarizes a May 2023 lab study on sucralose-6-acetate.This is a manufacturing impurity in…

  • New monoclonal antibodies designed to stop Epstein Barr virus from attaching to and entering human immune cells

    April 16, 2026

    Medical Mythbusting Commentary for April 16, 2026 Source:95% of people carry this virus and scientists may have just found how to stop it Reference:Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.

  • Facebook
  • X